Maker of promising Alzheimer’s drug Leqembi expects full FDA approval this summer, expanded Medicare coverage

“…in conjunction with BIOGEN…”
“Leqembi has shown promise in slowing the disease’s progression in that population, but it carries risks of brain swelling and bleeding.”

Biden first!

1 Like

Will the test group remember to take the medication as instructed? How can the results be verified? Oh yeah, trial data is no longer required…

3 Likes

I will stick with my Indian diet with amply applied Turmeric, thank you.

4 Likes